Merck beats earnings estimates as cancer drug Keytruda sales surged 12% Apr 30, 2026 · Cris Tolomia The drugmaker posted $16.29 billion in quarterly revenue, topping Wall Street forecasts, though a big acquisition charge pushed it to a net loss Read more »
.jpg?branch=production&format=jpg&width=1024)
.jpg?branch=production&format=jpg&width=1024)
.png?branch=production&format=jpg&width=1024)
